During September 2021, the RADAR-AD sub-study (tier 2) began. This is a multicentre, observational digital assessment study among participants with preclinical Alzheimer’s disease (AD), Mild Cognitive Impairment (MCI) due to AD and mild-to-moderate AD. The aim of the tier 2 study is similar to the aim of the main RADAR-AD study (tier 1) - to find and validate remote monitoring technologies (RMTs) which detect differences in daily life functioning in all stages of AD. The major difference between the two RADAR-AD tiers is the type of RMTs used. Whereas the main RADAR-AD study focuses on the use of wearables and smartphone applications, the tier 2 study employs fixed sensors, to be placed in RADAR-AD participants’ homes. Read more here.
